Leyden Laboratories
Protecting Now From What Comes Next
Leiden, Netherlands · Founded 2020
- Headquarters
- Leiden
- Employees
- 11–50
- Founded
- 2020
- Business Model
- B2B
About
Leyden Laboratories B.V. (Leyden Labs) is a clinical-stage biotechnology company based in Leiden, Netherlands, founded in 2020 and dedicated to protecting people from respiratory viruses through intranasal antibody-based sprays. The company's lead program, PanFlu, is a pan-influenza nasal spray that delivers broadly neutralizing antibodies directly to the nasal mucosa to stop infection before it takes hold, targeting both influenza A and B. Backed by GV, Softbank Vision Fund 2, Casdin Capital, F-Prime Capital, the Gates Foundation, and the European Investment Bank, Leyden Labs has raised over $100M to advance its pipeline through clinical trials.
Summary
Leyden Laboratories is a Biotech company based in Leiden, Netherlands, founded in 2020.
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Specialty pharmaceutical company
Biopharmaceutical services company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.